Navigation Links
iMedExchange Responses to Financial Crisis
Date:11/10/2008

Social Network for Physicians Conducting Teleconferences with Top-Ranked

Money Managers

SEATTLE, Nov. 10 /PRNewswire/ -- iMedExchange, the leading social network for physicians practicing in the U.S., is hosting a series of teleconferences for members featuring respected money managers moderating wide-ranging discussions of the causes and consequences of the current economic downturn and suggested courses of action recommended for physicians practicing in a time of economic uncertainty.

Hosted by iMedExchange, Sinnott Wealth Management will be presenting "Perspectives on Asset Allocation":

-- George and Debbie Sinnott of Sinnott Wealth Management will co-moderate

a discussion entitled "Perspectives on Asset Allocation." George is an

independent financial advisor whose practice focuses on medical

professionals, other high net worth individuals and successful small

business owners. Debbie is vice president of Sinnott Wealth

Management, specializing in client relations and financial analysis.

George and Debbie Sinnott will jointly moderate the discussion Nov. 10,

6 p.m. EDT.

-- Next month, Steven Abernathy -- an expert financial advisor named the

nation's top ranked money manager seven times by Thomson Financial's

Nelson World's Best Money Managers -- will headline a discussion

entitled "Update on the Markets." Abernathy is the founder of The

Abernathy Group, an investment firm widely noted for its "legacy

strategy" investment plans designed to safeguard the majority of a

client's wealth even in the event of a market catastrophe, while still

outperforming the S&P 500. He's been featured by CNNfn, Barron's and

on the cover of Money magazine.

"Our community is teeming with discussions of the current market turmoil and suggested responses -- both personal and professional -- to the meltdown of financial markets," said iMedExchange President Cliff Chirls. "We're responding by making some of the country's most respected money managers directly available to our members, and we expect that many are going to take advantage of the opportunity to receive well-considered, timely advice."

Several additional iMedExchange teleconferences will be conducted before the end of the year. Discussion topics include:

-- The federal bailout in perspective.

-- The impact on physician practices and finances.

Any practicing physicians registered as a member of iMedExchange can attend the teleconferences. For more information, please see http://www.imedexchange.com.

About iMedExchange

iMedExchange is a private online community for physicians, designed to foster professional and personal connections, increase productivity within the practice, and deliver career and lifestyle opportunities. The community is designed and supported by a team of Seattle and Silicon Valley-based technology, business and healthcare experts, and backed by a national team of physicians who provide guidance and insight. Online and side-by-side with the community, iMedExchange is making exciting progress towards building one of the most useful online networking sites for physicians. The active and growing community includes doctors from around the country with representation across a wide range of medical specialties.


'/>"/>
SOURCE iMedExchange
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Monitoring immune responses in disease
2. Study: Quick responses to influenza outbreaks reduces illness and death
3. Study finds unique HIV vaccine formula elicits strong immune responses
4. Aspen Institute to Release Presidential Candidates Responses to Health Care Reform Questionnaire; New Zogby Poll Findings Also to be Released
5. Undiagnosed OSA patients have altered cardiovascular responses during exercise recovery
6. Fires and Floods Lead the List of Largest Red Cross Disaster Responses
7. Blind humans lacking rods and cones retain normal responses to non-visual effects of light
8. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
9. Antibody responses in patients with Lyme arthritis
10. NIAID funds $51M contract to create comprehensive model of immune responses
11. Jazz Pharmaceuticals, Inc. to Announce Third Quarter Financial Results on November 13, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... Ongoing news of the ravages ... Association™ (ALCA) to conduct a survey that takes a closer look at cases of ... the prevalence and causes of TBI among the aging population, and identifies the challenges ...
(Date:2/10/2016)... ... February 10, 2016 , ... United Benefit Advisors (UBA), the ... addition to its growing list of Partner Firms. S.S. Nesbitt is headquartered ... to Huntsville and in between. , Harnessing the experience and insights of the ...
(Date:2/10/2016)... , ... February 10, 2016 , ... AxoGen, Inc. (NASDAQ: ... report results for the fourth quarter and full year ended December 31, 2015 on ... conference call and webcast for the investment community following the release at 4:30 PM ...
(Date:2/10/2016)... ... ... AHRA: The Association for Medical Imaging Management announced today ... as keynote speaker at the organization’s 2016 Spring Conference. Fox’s topic, Lead with ... with their own organizational staff and leadership. , “I am so excited ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact ... , Pioneering book "Better with Age: The Ultimate Guide to Brain Training" by award-winning ... improve memory. The book’s publication date is March 16, 2016. A free review ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... , February 10, 2016 --> --> ... Japan .  --> Japan .  --> A ... With submission, Shire continues to strengthen ... With submission, Shire continues to strengthen its presence ... submission, Shire continues to strengthen its presence ...
(Date:2/10/2016)... SEATTLE , Feb. 10, 2016  Resolve ... potentially transformative new approaches to the treatment of ... completion of a multiple ascending dose study in ... lead compound RSLV-132. --> ... double-blind, placebo-controlled multiple ascending dose study of RSLV-132 ...
(Date:2/10/2016)... YORK , Feb. 10, 2016 Immune ... biopharmaceutical company, announced today that it has filed a ... Leukemia and other cancers. --> ... treating cancer by administration of Ceplene (histamine dihydrochloride) in ... provides methods of predicting the efficacy of Ceplene and ...
Breaking Medicine Technology: